GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosis

Cell Death and Disease

Volumn 5, Issue , 2014, Pages

  Pantazi, E ^a   Gemenetzidis, E ^a   Trigiante, G ^a   Warnes, G ^a   Shan, L ^a   Mao, X ^a   Ikram, M ^a   Teh, M T ^a   Lu, Y J ^a   Philpott, M P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

aneuploidy; apoptosis; BCC; Bcl 2; genomic instability; GLI2

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; PROTEIN BCL 2; STRATIFIN; TRANSCRIPTION FACTOR GLI2; CELL CYCLE PROTEIN; GLI2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; NUCLEAR PROTEIN;

ANEUPLOIDY; APOPTOSIS; ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA DAMAGE; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; KERATINOCYTE; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRUCTURAL CHROMOSOME ABERRATION; TETRAPLOIDY; ULTRAVIOLET B RADIATION; BASAL CELL CARCINOMA; CHEMISTRY; CHROMOSOME ABERRATION; CYTOLOGY; DOWN REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; RADIATION EXPOSURE; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

APOPTOSIS; CARCINOMA, BASAL CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; DOWN-REGULATION; GENOMIC INSTABILITY; HUMANS; KERATINOCYTES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; ULTRAVIOLET RAYS;

EID: 84937966594     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.535     Document Type: Article

References (68)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
2. Jefford CE, Irminger-Finger I. Mechanisms of chromosome instability in cancers. Crit Rev Oncol Hematol 2006; 59: 1-14.
3. Lobrich M, Jeggo PA. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev 2007; 7: 861-869.
4. Zhivotovsky B, Kroemer G. Apoptosis and genomic instability. Nat Rev Mol Cell Biol 2004; 5: 752-762.
5. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432: 338-341.
6. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007; 17: 157-162.
7. Vitale I, Galluzzi L, Senovilla L, Criollo A, Jemaa M, Castedo M et al. Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ 2011; 18: 1403-1413.
8. Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358: 15-16.
9. Ribeiro GR, Francisco G, Teixeira LV, Romao-Correia RF, Sanches JA Jr, Neto CF et al. Repetitive DNA alterations in human skin cancers. J Dermatol Sci 2004; 36: 79-86.
10. Jayaraman SS, Rayhan DJ, Hazany S, Kolodney MS. Mutational landscape of basal cell carcinomas by whole exome sequencing. J Invest Dermatol 2014; 134: 213-220.
11. Teh MT, Blaydon D, Chaplin T, Foot NJ, Skoulakis S, Raghavan M et al. Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res 2005; 65: 8597-8603.
12. Janisson-Dargaud D, Durlach A, Lorenzato M, Grange F, Bernard P, Birembaut P. Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma. J Cutan Pathol 2008; 35: 916-921.
13. Jin Y, Martins C, Salemark L, Persson B, Jin C, Miranda J et al. Nonrandom karyotypic features in basal cell carcinomas of the skin. Cancer Genet Cytogenet 2001; 131: 109-119.
14. Pavarino EC, Antonio JR, Pozzeti EM, Larranaga HJ, Tajara EH. Cytogenetic study of neoplastic and nonneoplastic cells of the skin. Cancer Genet Cytogenet 1995; 85: 16-19.
15. Ashton KJ, Carless MA, Griffiths LR. Cytogenetic alterations in nonmelanoma skin cancer: a review. Genes Chromosomes Cancer 2005; 43: 239-248.
16. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev 2008; 8: 743-754.
17. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, Hui CC et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 2000; 24: 216-217.
18. Grachtchouk M, Pero J, Yang SH, Ermilov AN, Michael LE, Wang A et al. Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations. J Clin Invest 2011; 121: 1768-1781.
19. Hutchin ME, Kariapper MS, Grachtchouk M, Wang A, Wei L, Cummings D et al. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev 2005; 19: 214-223.
20. Ji J, Kump E, Wernli M, Erb P. Gene silencing of transcription factor Gli2 inhibits basal cell carcinomalike tumor growth in vivo. Int J Cancer 2008; 122: 50-56.
21. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324-331.
22. Zhang D, Cao L, Li Y, Lu H, Yang X, Xue P. Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy. World J Surg Oncol 2013; 11: 25.
23. Mazumdar T, DeVecchio J, Shi T, Jones J, Agyeman A, Houghton JA. Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res 2011; 71: 1092-1102.
24. Alexaki VI, Javelaud D, Van Kempen LC, Mohammad KS, Dennler S, Luciani F et al. GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst 2010; 102: 1148-1159.
25. Ruiz i Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev 2002; 2: 361-372.
26. Sterling JA, Oyajobi BO, Grubbs B, Padalecki SS, Munoz SA, Gupta A et al. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. Cancer Res 2006; 66: 7548-7553.
27. Storchova Z, Kuffer C. The consequences of tetraploidy and aneuploidy. J Cell Sci 2008; 121(Pt 23): 3859-3866.
28. Thiyagarajan S, Bhatia N, Reagan-Shaw S, Cozma D, Thomas-Tikhonenko A, Ahmad N et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells. Cancer Res 2007; 67: 10642-10646.
29. Snijders AM, Huey B, Connelly ST, Roy R, Jordan RC, Schmidt BL et al. Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene. Oncogene 2008; 28: 625-637.
30. Hirotsu M, Setoguchi T, Sasaki H, Matsunoshita Y, Gao H, Nagao H et al. Smoothened as a new therapeutic target for human osteosarcoma. Mol Cancer 2010; 9: 5.
31. Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P et al. Apoptosis regulation in tetraploid cancer cells. EMBO J 2006; 25: 2584-2595.
32. Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998; 18: 1055-1064.
33. Storchova Z, Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 2004; 5: 45-54.
34. Borel F, Lohez OD, Lacroix FB, Margolis RL. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket proteincompromised cells. Proc Natl Acad Sci USA 2002; 99: 9819-9824.
35. Margolis RL, Lohez OD, Andreassen PR. G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 2003; 88: 673-683.
36. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 2001; 12: 1315-1328.
37. Lodygin D, Yazdi AS, Sander CA, Herzinger T, Hermeking H. Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 2003; 22: 5519-5524.
38. Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 2004; 64: 7724-7731.
39. Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, Jin S et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 2008; 68: 3421-3428.
40. Vogler M, Dinsdale D, Dyer MJ, Cohen GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 2009; 16: 360-367.
41. Ikram MS, Neill GW, Regl G, Eichberger T, Frischauf AM, Aberger F et al. GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. J Invest Dermatol 2004; 122: 1503-1509.
42. Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, Koller J et al. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. Oncogene 2002; 21: 5529-5539.
43. Tojo M, Kiyosawa H, Iwatsuki K, Nakamura K, Kaneko F. Expression of the GLI2 oncogene and its isoforms in human basal cell carcinoma. Br J Dermatol 2003; 148: 892-897.
44. O'Driscoll L, McMorrow J, Doolan P, McKiernan E, Mehta JP, Ryan E et al. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays. Mol Cancer 2006; 5: 74.
45. Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, Mohar A et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 2006; 27: 337-343.
46. Shi Q, King RW. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 2005; 437: 1038-1042.
47. Miller SJ. Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 1991; 24: 1-13.
48. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005; 437: 1043-1047.
49. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci USA 1996; 93: 7081-7084.
50. Duelli D, Lazebnik Y. Cell-to-cell fusion as a link between viruses and cancer. Nat Rev 2007; 7: 968-976.
51. Wilker EW, van Vugt MA, Artim SA, Huang PH, Petersen CP, Reinhardt HC et al. 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature 2007; 446: 329-332.
52. Lodygin D, Hermeking H. The role of epigenetic inactivation of 14-3-3sigma in human cancer. Cell Res 2005; 15: 237-246.
53. Duensing A, Ghanem L, Steinman RA, Liu Y, Duensing S. p21(Waf1/Cip1) deficiency stimulates centriole overduplication. Cell Cycle (Georgetown, TX) 2006; 5: 2899-2902.
54. Fukasawa K. Oncogenes and tumour suppressors take on centrosomes. Nat Rev 2007; 7: 911-924.
55. Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 2008; 180: 665-672.
56. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1: 3-11.
57. Dhar S, Squire JA, Hande MP, Wellinger RJ, Pandita TK. Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability. Mol Cell Biol 2000; 20: 7764-7772.
58. Mantel C, Braun SE, Reid S, Henegariu O, Liu L, Hangoc G et al. p21(cip-1/waf-1) deficiency causes deformed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells. Blood 1999; 93: 1390-1398.
59. Stewart ZA, Leach SD, Pietenpol JA. p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol Cell Biol 1999; 19: 205-215.
60. Nelson DA, Tan TT, Rabson AB, Anderson D, Degenhardt K, White E. Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes Dev 2004; 18: 2095-2107.
61. Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA. Role of apoptosis in basal cell and squamous cell carcinoma formation. Immunol Lett 2005; 100: 68-72.
62. Kump E, Ji J, Wernli M, Hausermann P, Erb P. Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis. Oncogene 2008; 27: 3856-3864.
63. Deng H, Lin Q, Khavari PA. Sustainable cutaneous gene delivery. Nat Biotechnol 1997; 15: 1388-1391.
64. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000; 20: 1436-1447.
65. Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M et al. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One 2009; 4: e4849.
66. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology 2002; 3: research0034.1-research0034.11.
67. Mao X, Young BD, Chaplin T, Shipley J, Lu YJ. Subtle genomic alterations and genomic instability revealed in diploid cancer cell lines. Cancer Lett 2008; 267: 49-54.
68. Strefford JC, Lillington DM, Young BD, Oliver RT. The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines: a comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data. Cancer Genet Cytogenet 2001; 124: 112-121.